Fluvoxamine, melatonin and COVID-19

被引：0
|
作者：
George M. Anderson
机构：
[1] Yale University School of Medicine,Child Study Center and the Department of Laboratory Medicine
来源：
Psychopharmacology | 2021年 / 238卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：611 / 611
相关论文
共 50 条
  • [1] Fluvoxamine, melatonin and COVID-19
    Anderson, George M.
    [J]. PSYCHOPHARMACOLOGY, 2021, 238 (02) : 611 - 611
  • [2] Fluvoxamine for COVID-19?
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1623): : 69 - 70
  • [3] Fluvoxamine in COVID-19
    Devi, Sharmila
    [J]. LANCET INFECTIOUS DISEASES, 2024, 24 (01): : E23 - E23
  • [4] Heme oxygenase agonists—fluvoxamine, melatonin—are efficacious therapy for Covid-19
    Philip L. Hooper
    [J]. Cell Stress and Chaperones, 2022, 27 : 3 - 4
  • [5] Fluvoxamine for the treatment of COVID-19
    Marzolini, Catia
    Marra, Fiona
    Boyle, Alison
    Khoo, Saye
    Back, David J.
    [J]. LANCET GLOBAL HEALTH, 2022, 10 (03): : E331 - E331
  • [6] Fluvoxamine for the treatment of COVID-19
    Nyirenda, John L. Z.
    Sofroniou, Mario
    Toews, Ingrid
    Mikolajewska, Agata
    Lehane, Cornelius
    Monsef, Ina
    Abu-taha, Aesha
    Maun, Andy
    Stegemann, Miriam
    Schmucker, Christine
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (09):
  • [7] Trial of fluvoxamine in COVID-19
    Kang, Seema
    [J]. LANCET PSYCHIATRY, 2022, 9 (01): : 17 - 17
  • [8] Heme oxygenase agonists-fluvoxamine, melatonin-are efficacious therapy for Covid-19
    Hooper, Philip L.
    [J]. CELL STRESS & CHAPERONES, 2022, 27 (01): : 3 - 4
  • [9] Fluvoxamine for COVID-19 ICU patients?
    Trkulja, Vladimir
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2454 - 2455
  • [10] Lack of Benefit of Fluvoxamine for COVID-19
    Bhimraj, Adarsh
    Gallagher, Jason C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (04): : 291 - 292
12345